Elicio Therapeutics Inc
(ELTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -51,898 | -35,195 | -28,208 | -54,573 | -80,107 |
| Depreciation Amortization | 1,253 | 1,170 | 1,057 | 2,685 | 8,289 |
| Accounts receivable | N/A | N/A | N/A | -806 | 440 |
| Accounts payable and accrued liabilities | -3,331 | 23 | 1,125 | -866 | -5,607 |
| Other Working Capital | 3,959 | -57 | -150 | -25,970 | 25,769 |
| Other Operating Activity | 12,949 | 1,365 | 3,997 | 26,887 | 28,328 |
| Operating Cash Flow | $-37,068 | $-32,694 | $-22,179 | $-52,643 | $-22,888 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -84 | -32 | -654 | -382 | -41 |
| Investing Cash Flow | $-84 | $-32 | $-654 | $-382 | $-41 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 19,727 | 10,000 | N/A | 302 | 32,118 |
| Debt Repayment | N/A | N/A | N/A | -9 | N/A |
| Common Stock Issued | 23,143 | 7,126 | 82 | 109,346 | 280 |
| Common Stock Repurchased | N/A | N/A | N/A | -10 | N/A |
| Other Financing Activity | -549 | 21,487 | 21,120 | -2,458 | 20,011 |
| Financing Cash Flow | $42,321 | $38,613 | $21,202 | $107,171 | $52,409 |
| Exchange Rate Effect | 22 | N/A | N/A | 3 | -444 |
| Beginning Cash Position | 14,301 | 8,414 | 10,045 | 34,607 | 5,571 |
| End Cash Position | 19,492 | 14,301 | 8,414 | 88,756 | 34,607 |
| Net Cash Flow | $5,191 | $5,887 | $-1,631 | $54,149 | $29,036 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,068 | -32,694 | -22,179 | -52,643 | -22,888 |
| Capital Expenditure | -87 | -66 | -654 | -382 | -41 |
| Free Cash Flow | -37,155 | -32,760 | -22,833 | -53,025 | -22,929 |